Standard BioTools Inc. Workers' Compensation Liability, Current
Standard BioTools Inc. (LAB) had Workers' Compensation Liability, Current of $7.34 million as of 2023-12-31, per its 10-K filed 2024-03-01.
Discontinued › Notes › Payables and Accruals › Accrued Liabilities, Current › Employee-related Liabilities, Current
us-gaap:WorkersCompensationLiabilityCurrent · last filed 2024-03-01
- 2023-12-31: Workers' Compensation Liability, Current $7.34M.
- 2023-09-30: Workers' Compensation Liability, Current $5.58M.
- 2023-06-30: Workers' Compensation Liability, Current $3.69M.
- 2023-03-31: Workers' Compensation Liability, Current $1.80M.
| Period end | Workers' Compensation Liability, Current | Workers' Compensation Liability, Current as first filed |
|---|---|---|
| 2023-12-31 | $7.34M 10-K · filed 2024-03-01 | |
| 2023-09-30 | $5.58M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $3.69M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $1.80M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $1.17M 10-K · filed 2024-03-01 | |
| 2022-09-30 | $1.93M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $264.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.78M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $14.00K 10-K · filed 2023-03-14 | $40.00K 10-K · filed 2022-03-08 |
| 2021-09-30 | $2.37M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $2.33M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $2.35M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $7.84M 10-K · filed 2022-03-08 | |
| 2019-12-31 | $1.59M 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |